Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2026
CRISPR Therapeutics reports quarterly earnings
CRISPR Therapeutics reported quarterly earnings data, including EPS of ($1.15), missing the consensus estimate of ($1.04) by $0.11, and revenue of $12.67 million.